Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-28T14:24:53.178Z Has data issue: false hasContentIssue false

22 - Medical illness and the risk of pre-eclampsia

from Part II - Clinical Practice

Published online by Cambridge University Press:  03 September 2009

Fiona Lyall
Affiliation:
University of Glasgow
Michael Belfort
Affiliation:
University of Utah
Get access

Summary

Introduction

Many different medical illnesses predispose women to pre-eclampsia. Some of these are logical, well known, and accepted, such as pre-existing hypertension or diabetes. Others are less well known or more controversial, such as migraine and asthma. Correct identification of women at increased risk for pre-eclampsia allows appropriate channeling of antenatal care and allocation of resources to maximize the chances of early diagnosis and appropriate management. In addition, strategies to screen for and prevent pre-eclampsia are often more effective in high-risk women. It is important that women with medical diseases associated with an increased risk of pre-eclampsia and the related complications of intrauterine growth restriction and prematurity are appropriately counseled, ideally prior to pregnancy. In many cases appropriate and optimal pre-conception control of the medical illness may reduce the risk of pre-eclampsia.

The risk factors for pre-eclampsia are listed in Table 22.1. This chapter will cover the general, obstetric and medical risk factors. These general and obstetric risk factors are discussed since, although not representing medical illness themselves, they may often complicate or coexist with medical illness. They may therefore add to the already elevated risk of pre-eclampsia associated with the medical illness, e.g. obese women who are more likely to be hypertensive. Medical illness may affect fertility resulting in a delay before child bearing or longer interbirth interval, e.g. women with renal failure who have reduced fertility. It is the individualized cumulative risk of these various factors that is important for clinical practice.

Type
Chapter
Information
Pre-eclampsia
Etiology and Clinical Practice
, pp. 325 - 338
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abalos, E., Duley, L., Steyn, D. W. and Henderson-Smart, D. J. (2003). Antihypertensive drug therapy for mild to moderate hypertension in pregnancy (Cochrane Review). In The Cochrane Library, Issue 1, 2003. Oxford: Update Software.Google Scholar
ACOG Practice Bulletin #29, July 2001. Chronic Hypertension in Pregnancy.
Alfirevic, Z., Mousa, H. A., Martlew, V., Briscoe, L., Perez-Casal, M. and Toh, C. H. (2001). Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet. Gynecol., 97, 753–9.Google ScholarPubMed
Alfirevic, Z., Roberts, D. and Martlew, V. (2002). How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol., 101, 6–14.CrossRefGoogle ScholarPubMed
Armenti, V. T., Ahlswede, K. M., Ahlswede, B. A., et al. (1995). Variables affecting birth weight and graft survival in 197 pregnancies in cyclosporin treated female kidney transplant recipients. Transplantation, 59, 476.CrossRefGoogle ScholarPubMed
Armenti, V. T., Moritz, M. J. and Davison, J. M. (1998). Medical management of the pregnant transplant recipient. Adv. Renal Reprod. Ther., 5, 14–23.CrossRefGoogle ScholarPubMed
Backos, M., Rai, , R., Baxter, N., Chilcott, I. T., Cohen, H. and Regan, L. (1999). Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br. J. Obstet. Gynaecol., 106, 102–7.CrossRefGoogle ScholarPubMed
Bianco, A. T., Stone, J., Lynch, L., Lapinski, R., Berkowitz, G. and Berkowitz, R. L. (1996). Pregnancy outcome at age 40 and older. Obstet. Gynecol., 87, 917–22.CrossRefGoogle ScholarPubMed
Bianco, A. T., Smilen, S. W., Davis, Y., Lopez, S., Lapinski, R. and Lockwood, C. J. (1998). Pregnancy outcome and weight gain recommendations for the morbidly obese woman. Obstet. Gynecol., 91, 97–102.CrossRefGoogle ScholarPubMed
Bobrowski, R. A. and Bottoms, S. F. (1995). Underappreciated risks of the elderly multipara. Am. J. Obstet. Gynaecol., 172, 1764.CrossRefGoogle ScholarPubMed
Confidential Enquiries into Maternal and Child Health (2004). Why mothers die 2000–02. 6th Confidential Enquiry into Maternal Deaths in the United Kingdom. London: RCOG Press.
Conde-Agudelo, A. and Belizan, J. M. (2000a). Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. Br. J. Obstet. Gynaecol., 107, 75–83.CrossRefGoogle Scholar
Conde-Agudelo, A. and Belizan, J. M. (2000b). Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study. Br. Med. J., 321, 1255–9.CrossRefGoogle Scholar
Cooper, W. O., Hernandez-Dias, S., Arbogast, P. G., et al. (2006). Major congenital malformations after first-trimester exposure to ACE inhibitors. N. Engl. J. Med., 354, 2443–51.CrossRefGoogle ScholarPubMed
Davison, J. and Baylis, C. (2002). Renal disease. In Medical Disorders in Obstetric Practice, 4th edn., ed. Swiet, M.. Oxford: Blackwell, pp. 198–266.CrossRefGoogle Scholar
Department of Health, Welsh Office, Scottish Home and Health Department and Department of Health and Social Services, Northern Ireland. (2001). Confidential Enquiries into Maternal Deaths in the United Kingdom 1997–99. London: Royal College of Obstetricians and Gynaecologists.
Douglas, K. and Redman, C. W. (1994). British Eclampsia Survey. Br. Med. J., 309, 1395–400.CrossRefGoogle Scholar
Drakeley, A. J., LeRoux, P. A., Anthony, J. and Penny, J. (2002). Acute renal failure complicating severe pre-eclampsia requiring admission to an obstetric intensive care unit. Am. J. Obstet. Gynecol., 186, 253–6.CrossRefGoogle Scholar
Duckitt, K. and Harrington, D. (2005). Risk factors for pre-eclampsia at antenatal booking: a systematic review of controlled studies. Br. Med. J., 330, 565–7.CrossRefGoogle ScholarPubMed
Ekbom, P., Damm, P., Feldt-Rasmussen, B., Feldt-Rasmussen, U., Molvig, J. and Mathiesen, E. R. (2001). Pregnancy outcome in type I diabetic women with microalbuminuria. Diabetes Care, 24, 1739–44.CrossRefGoogle ScholarPubMed
Epstein, F. H. (1996). Pregnancy and renal disease. N. Engl. J. Med., 335, 277–8.CrossRefGoogle ScholarPubMed
Farquharson, R., Quenby, S. and Greaves, M. (2002). Antiphospholipid syndrome in pregnancy. A randomised, controlled trial of treatment. Obstet. Gynaecol., 100, 408–13.CrossRefGoogle Scholar
Garner, P. R., D'Alton, M. E., Dudley, D. K., Huard, P. and Hardie, M. (1990). Pre-eclampsia in diabetic pregnancies. Am. J. Obstet. Gynecol., 163, 505–8.CrossRefGoogle ScholarPubMed
Granger, K. A. and Farquharson, R. G. (1997). Obstetric outcome in antiphospholipid syndrome. Lupus, 6, 509–13.CrossRefGoogle ScholarPubMed
Hiilesmaa, V., Suhonen, L. and Teramo, K. (2000). Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia, 43, 1534–9.CrossRefGoogle Scholar
Huong, D. L., Wechsler, B., Bletry, O., Vauthier-Brouzes, D., Lefebvre, G. and Piette, J. C. (2001a). A study of 75 pregnancies in patients with antiphospholipid syndrome. J. Rheumatol., 28, 2025–30.Google Scholar
Huong, D. L., Wechsler, B., Vauthier-Brouzes, D., Beaufils, H., Lefebvre, G. and Piette, J. C. (2001b). Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann. Rheum. Dis., 60, 599–604.CrossRefGoogle Scholar
Irgens, H. U., Reisaeter, L., Irgens, L. M. and Lie, R. T. (2001). Long-term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br. Med. J., 323, 1213–17.CrossRefGoogle ScholarPubMed
Jones, D. C. and Hayslett, J. P. (1996). Outcome of pregnancy in women with moderate or severe renal insufficiency. N. Engl. J. Med., 335, 226–32.CrossRefGoogle ScholarPubMed
Jungers, P. and Chauveau, D. (1997). Pregnancy in renal disease. Kidney Int., 52, 871–85.CrossRefGoogle ScholarPubMed
Levine, J. S., Ware-Branch, D. and Rauch, J. (2002). The Antiphospholipid Syndrome. N. Engl. J. Med., 346, 752–63.CrossRefGoogle ScholarPubMed
Khamashta, M. A. and Hughes, G. R. V. (1997). Pregnancy in systemic lupus erythematosus. Curr. Opin. Rheumatol., 8, 424–9.CrossRefGoogle Scholar
Kutteh, W. H. (1996). Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am. J. Obstet. Gynecol., 174, 1574–89.CrossRefGoogle ScholarPubMed
Laskin, C. A., Bombardier, C., Hannah, M. E., et al. (1997). Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N. Engl. J. Med., 337, 148–53.CrossRefGoogle ScholarPubMed
Lee, C. J., Hsieh, T. T., Chiu, T. H., et al. (2000). Risk factors for pre-eclampsia in an Asian population. Int. J. Gynecol. Obstet., 70, 327–33.CrossRefGoogle Scholar
Lehmann, D. K. and Chism, J. (1987). Pregnancy outcome in medically complicated and uncomplicated patients aged 40 years or older. Am. J. Obstet. Gynecol., 157, 738–42.CrossRefGoogle ScholarPubMed
Lima, F., Khamashta, M. A., Buchanan, N. M., Kerslake, S., Hunt, B. J. and Hughes, G. R. (1996). A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin. Exp. Rheumatol., 14, 131–6.Google ScholarPubMed
Mabie, W. C., Pernoll, M. L. and Biswas, M. K. (1986). Chronic hypertension in pregnancy. Obstet. Gynecol., 67, 197–205.CrossRefGoogle ScholarPubMed
Magee, L. A., Ornstein, M. P. and Dadelszen, P. (1999). Management of hypertension in pregnancy. Br. Med. J., 318, 1332–6.CrossRefGoogle ScholarPubMed
McCowan, L. M. E., Buist, R. G., North, R. A. and Gamble, G. (1996). Perinatal morbidity in chronic hypertension. Br. J. Obstet. Gynaecol., 103, 123–9.CrossRefGoogle ScholarPubMed
Moodley, J., Bhoola, V., Duursma, J., Pudifin, D., Byrne, S. and Kenoyer, D. G. (1995). The association of APA with severe early-onset pre-eclampsia. S. Afr. Med. J., 85, 105–7.Google Scholar
Nelson-Piercy, C. (1999). Thrombophilia and adverse pregnancy outcome: has the time come for routine testing?Br. J. Obstet. Gynaecol., 106, 513–15.CrossRefGoogle Scholar
Nelson-Piercy, C. (2006). Hypertension and pre-eclampsia. In Handbook of Obstetric Medicine, third edn., ed. Nelson-Piercy, C.. London: Informa Healthcare.Google Scholar
Nelson-Piercy, C. and Khamastha, M. (2003). Autoimmune rheumatic disorders and vasculitis in pregnancy. In Oxford Textbook of Medicine, 4th edn., ed. Weatherall, D., Cunningham, J. and Firth, J.. Oxford: Oxford University Press.Google Scholar
O'Shaughnessy, K. M., Fu, B., Ferraro, F., Lewis, I., Downing, S. and Morris, N. H. (1999). Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variations in an East Anglian preeclampsia cohort. Hypertension, 33, 1338–41.CrossRefGoogle Scholar
Powers, R. W., Minich, L. A., Lykins, D. L., Ness, R. B., Crombleholme, W. R. and Roberts, J. M. (1999). Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to pre-eclampsia. J. Soc. Gynecol. Invest., 6, 74–9.CrossRefGoogle Scholar
Rai, R., Cohen, H., Dave, M. and Regan, L. (1997). Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br. Med. J., 314, 253–7.CrossRefGoogle Scholar
Rey, E. and Couturier, A. (1994). The prognosis of pregnancy in women with chronic hypertension. Am. J. Obstet. Gynecol., 171, 410.CrossRefGoogle ScholarPubMed
Rey, E., Kahn, S. R., David, M. and Shrier, I. (2003). Thrombophilic disorders and fetal loss: a meta-analysis. Lancet, 361, 901–8.CrossRefGoogle ScholarPubMed
Ros, H. S., Cnattingius, S. and Lipworth, L. (1998). Comparison of risk factors for pre-eclampsia and gestational hypertension in a population based cohort study. Am. J. Epidemiol., 147, 1062–70.CrossRefGoogle Scholar
Salha, O., Sharma, V., Dada, T., et al. (1999). The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum. Reprod., 14, 2268–73.CrossRefGoogle ScholarPubMed
Sattar, N., Clark, P., Lean, M., Holmes, A., Walker, I. and Greer, I. A. (2001). Antenatal waist circumference and hypertension risk. Obstet. Gynaecol., 97(2), 268–71.Google ScholarPubMed
Schatz, M., Zeiger, R. S., Harden, K., et al. (1997). The safety of asthma and allergy medications during pregnancy. J. Allergy Clin. Immunol., 100, 301–6.CrossRefGoogle ScholarPubMed
Schatz, M. and Dombrowski, M. (2000). Outcomes of pregnancy in asthmatic women. Immun. Allerg. Clin. N. A., 20, 715–27.CrossRefGoogle Scholar
Sermer, M., Naylor, C. D., Farine, D., et al. (1998). The Toronto Tri-Hospital Gestational Project. Diabetes Care, 21 (Suppl. 2), B33–42.Google ScholarPubMed
Sibai, B. M., Abdella, T. N. and Anderson, G. D. (1983). Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet. Gynecol., 61, 571–6.Google ScholarPubMed
Sibai, B. M., Mabie, B. C., Harvey, R. N. and Gonzalez, A. R. (1987). Pulmonary edema in severe preeclampsia–eclampsia: analysis of thirty-seven consecutive cases. Am. J. Obstet. Gynecol., 156, 1174–9.CrossRefGoogle ScholarPubMed
Sibai, B. M., Ramadan, M. K., Usta, I., Salama, M., Mercer, B. M. and Friedman, S. A. (1993). Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am. J. Obstet. Gynecol., 1993, 169, 1000–6.CrossRefGoogle Scholar
Sibai, B. M., Ewell, M., Levine, R. J., et al. (1997). Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Pre-eclampsia Prevention (CPEP) Study Group. Am. J. Obstet. Gynecol., 177, 1003–10.CrossRefGoogle ScholarPubMed
Sibai, B. M. (2000). Risk factors, pregnancy complications, and prevalence of hypertensive disorders in women with pregravid diabetes mellitus. J. Matern. Fetal. Med., 9, 62–5.Google ScholarPubMed
Skjaerven, R., Wilcox, A. J. and Lie, R. T. (2002). The interval between pregnancies and the risk of pre-eclampsia. N. Engl. J. Med., 346, 33–8.CrossRefGoogle Scholar
Smith, G. C. S., Pell, J. P. and Walsh, D. (2001). Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet, 357, 2002–6.CrossRefGoogle ScholarPubMed
Triolo, G., Ferrante, A., Ciccia, F., Accardo-Palumbo, A., et al. (2003). Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum., 48, 728–31.CrossRefGoogle ScholarPubMed
Hoorn, J., Dekker, G. and Jeffries, B. (2002). Gestational diabetes versus obesity as risk factors for pregnancy-induced hypertensive disorders and fetal macrosomia. Aust. N. Z. J. Obstet. Gynaecol., 42, 29–34.CrossRefGoogle ScholarPubMed
Wang, J. X., Knottnerus, A. M., Schuit, G., Norman, R. J., Chan, A. and Dekker, G. A. (2002). Surgically obtained sperm and the risk of gestational hypertension and pre-eclampsia. Lancet, 359, 673–4.CrossRefGoogle ScholarPubMed
Ware-Branch, D. (1994). Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome. Lupus, 3, 275–80.CrossRefGoogle Scholar
Ware-Branch, D. W., Silver, R. M., Blackwell, J. L., Reading, J. C. and Scott, J. R. (1992). Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet. Gynecol., 80, 614–20.Google Scholar
Ware-Branch, D. and Khamashta, M. A. (2003). Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet. Gynecol., 101, 1333–44.Google Scholar
Wen, S. W., Demissie, K. W. and Liu, S. (2001). Adverse outcomes in pregnancies of asthmatic women: results from a Canadian population. Ann. Epidemiol., 11, 7–12.CrossRefGoogle ScholarPubMed
Wilson, B. J., Watson, M. S., Prescott, G. J., et al. (2003). Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. Br. Med. J., 326, 845–9.CrossRefGoogle ScholarPubMed
Wilson, W. A., Gharavi, A. E., Koike, T., et al. (1999). International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop. Arthritis Rheumat., 42, 1309–11.3.0.CO;2-F>CrossRefGoogle ScholarPubMed
Xiong, X., Saunders, L. D., Wang, F. L. and Demianczuk, N. N. (2001). Gestational diabetes: prevalence, risk factors, maternal and fetal outcomes. Int. J. Gynaecol. Obstet., 75, 221–8.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×